Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

“We found that treating patients before bariatric surgery with semaglutide, one of the new GLP-1 medications ... the GLP-1s were given months to years after bariatric surgery, perhaps when ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Follow-up periods ranged from 1 month to 4 years after the index date. The use of semaglutide was associated with an increased risk for NAION among patients with diabetes throughout the study ...

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

New study reveals semaglutide ... at one year. Adult patients with a body mass index (BMI) of at least 30 kg/m 2 who completed a follow-up weight measurement at least 12 months after treatment ...